Safe Orthopaedics announces the installation of a second SORA unit
in France and will accelerate the SORA program in the second
quarter of 2022
Safe Orthopaedics announces the
installation of a second SORA unit in France and will accelerate
the SORA program in the second quarter of
2022
- Several dozen surgeries validate the SORA
model,
- Installation of a second unit at the Saint Charles
Clinic (Lyon),
- Scheduled acceleration of the program starting in the
second quarter of 2022.
|
|
|
|
Eragny-sur-Oise, France, May 12nd, 2022
08h45 CET – Safe (FR0013467123 – ALSAF), a
company specializing in the design, manufacturing and marketing of
single-use technologies for spinal surgeries, delivering the safest
treatment for spinal fractures urgently treated, announces the
installation of a second SORA unit in France and wishes to
accelerate the SORA program.
Safe Orthopaedics reminds the value of SORA:
- Assisted selection of
implants and instruments in the operating room: SORA eliminates the
risk of error in product selection, tracks lot numbers and informs
all relevant hospital departments of what has been implanted.
- Automated replenishment and
inventory management support: Through the automated ordering
process, SORA reduces delivery times after each operation, improves
operational planning, and reduces hospital lead times, resources
and logistics costs.
- Virtual assistant for
surgeons and medical staff: SORA's surgical documentation of
implants and instruments is accessible via the software and online
surgical assistance. SORA offers virtual assistance via the
interactive touch screen. Safe Orthopaedics experts can also be
invited virtually to answer questions before, during and after
surgery.
As announced on November 9, 2021, a first SORA
unit had been installed at the Convert Clinic in Bourg-en-Bresse
and evaluated by Dr. Vallèse and Dr. Afathi and their medical
team.
Dr. Pierre Vallèse, orthopedic
surgeon, explains, "Sora was a bit of a challenge for our
OR team, but within a few weeks it had found its place. It is easy
to use with an ergonomic and intuitive digital application. We
quickly became aware of the benefits of this solution on several
levels:- The management of implants is facilitated with an
immediate control of the stock and a restocking ensured directly
from the user to the manufacturer. SORA guarantees the availability
of the implants and informs the team before the start of the
operation.- The collection of data concerning implant placements
allows the stock in place to be personalized over time. SORA
ensures implant traceability that could easily be integrated into
digital clinical monitoring solutions. - Team training is ensured
by technical data sheets accessible at any time on the application,
as well as by remote video assistance if needed. SORA is a window
from the OR to the industry."
Dr. Mehdi Afathi, Neurosurgeon in
Bourg-en-Bresse, confirms "After a few
months of using SORA at the Convert clinic, we can see the interest
of this platform for us, the surgeons, for the operating room team,
and for the clinic's pharmacy. The operating room nurses, who are
in direct contact with SORA, were able to "get the hang of it"
quite quickly and now master its use without any problem. We note
that thanks to SORA, the stocks necessary for the activity of
regulated and urgent spinal surgery are always present, thanks to
the automatic replenishment. This improves the safety of the
patient who can benefit from the optimal procedure at any time, and
relieves the entire team, especially in the pharmacy, whose
workload is to some extent reduced."
Safe Orthopaedics announces the installation of
a second unit at the Saint-Charles clinic and plans to install the
third unit in a French university hospital in the coming weeks to
finalize its French evaluation and prove its value in centers of
different size and organization.
In the second half of the year, Safe
Orthopaedics aims at a faster deployment in France, evaluations in
Germany and the USA (centers already identified) and new
functionalities.
"First of all, I would like to thank Dr.
Vallèse, Dr. Afathi and their teams for their involvement in this
project. In a few months of use, we have tested, improved and
imagined the future functionalities of SORA. In addition to the
advantages explained by Drs. Vallèse and Afathi, we have noted an
increase in the number of surgeries performed at the convert
clinic, a reduction in delivery times and in inventories, all of
which serve both the clinic's medico-economic and Safe's financial
interests," commented Pierre Dumouchel, Chairman and CEO of
Safe Group. "New digital functionalities are planned for
May and the international deployment of SORA is still planned for
the second half of the year, in line with our 2022 strategic plan.
In the medium term, we are aiming to have SORA installed in all our
major accounts”.
About Safe GroupSafe Group is a
French medical technology group that brings together Safe
Orthopaedics, a pioneer in ready-to-use technologies for spine
pathologies, and Safe Medical (formerly LCI Medical), a medical
device subcontractor for orthopedic surgery. The group employs
approximately 150 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and single-use instruments, available at
any time to the surgeon. These technologies are part of a minimally
invasive approach aimed at reducing the risks of contamination and
infection, in the interest of the patient and with a positive
impact on hospitalization times and costs. Protected by 18
patent families, SteriSpineTM kits are CE marked and FDA approved.
Safe Orthopaedics is headquartered in the Paris region (95610
Eragny-sur-Oise) and has subsidiaries in the United Kingdom,
Germany, the United States and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
www.safeorthopaedics.com
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation center
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and in Tunisia, offering numerous industrial services:
design, industrialization, machining, finishing and sterile
packaging. Supported by the French stimulus plan in 2020, the
company invests in additive printing and will be operational in
2022 on this new technology.
For more information: www.safemedical.fr
Contacts
Safe
Group
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50
00
investors@safeorthopaedics.com
Press RelationsUlysse
CommunicationPierre-Louis Germain / +33 (0)6 64 79
97 51 / plgermain@ulysse-communication.com
Bruno Arabian / +33 (0)6 87 88 47 26 /
barabian@ulysse-communication.com
- 20220512 - PR_SORA no photo
SAFE (EU:ALSAF)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
SAFE (EU:ALSAF)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024